Exhaled breath 8-isoprostane as a marker of asthma severity

Archives of Medical Science

Volumn 8, Issue 3, 2012, Pages 515-520

  Piotrowski, Wojciech J ^a   Majewski, Sebastian ^a   Marczak, Jerzy ^a   Kurmanowska, Zofia ^a   Górski, Paweł ^a   Antczak, Adam ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

8 isoprostane; Exhaled breath condensate; Oxidative stress; Severe asthma

Indexed keywords

8 ISOPROSTANE; STEROID;

ADULT; ARTICLE; ASTHMA; ASTHMA CONTROL TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; EXHALED BREATH CONDENSATE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; MALE; PATIENT MONITORING; PEAK EXPIRATORY FLOW; RESPIRATORY TRACT PARAMETERS; SPIROMETRY; STEROID THERAPY; WAKEFULNESS;

EID: 84863927728     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.28639     Document Type: Article

References (23)

1. Gina Report, Global Strategy for Asthma Management and Prevention. Updated 2008. www.ginasthma.org. Accessed May 5th 2010.
2. Jenkins HA, Cool C, Szefler SJ, et al. Histopathology of severe childhood asthma: a case series. Chest 2003; 124: 32-41. (Pubitemid 36851328)
3. Frey U, Suki B. Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet 2008; 372: 1088-99.
4. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154: 1055-60.
5. Ciencewicki J, Trivedi S, Kleeberger SR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol 2008; 122: 456-68.
6. Corradi M, Montuschi P, Donnelly LE, Pesci A, Kharitonov SA, Barnes PJ. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 2001; 163: 854-8. (Pubitemid 32275854)
7. Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000; 162: 1273-6.
8. Nightingale JA, Rogers DF, Barnes PJ. Effect of inhaled ozone on exhaled nitric oxide, pulmonary function, and induced sputum in normal and asthmatic subjects. Thorax 1999; 54: 1061-9.
9. Formanek W, Inci D, Lauener RP, Wildhaber JH, Frey U, Hall GL. Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J 2002; 19: 487-91. (Pubitemid 34256964)
10. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-203.
11. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160: 216-20. (Pubitemid 29326091)
12. Antczak A, Montuschi P, Kharitonov S, Gorski P, Barnes PJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002; 166: 301-6. (Pubitemid 34864417)
13. Montuschi P, Nightingale JA, Kharitonov SA, Barnes PJ. Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide. Free Radic Biol Med 2002; 33: 1403-8. (Pubitemid 35284923)
14. Carraro S, Cogo PE, Isak I, et al. EIA and GC/MS analysis of 8-isoprostane in EBC of children with problematic asthma. Eur Respir J 2010; 35: 1364-9.
15. Samitas K, Chorianopoulos D, Vittorakis S, et al. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Respir Med 2009; 103: 750-6.
16. Boros P, Franczuk M, Wesołowski S. Polish Respiratory Society recommendations for spirometry assessments [Polish]. Pneumonol Alergol Pol 2006; suppl. 1.
17. Horvath I, Hunt J, Barnes PJ, et al ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-48. (Pubitemid 41264218)
18. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65. (Pubitemid 38096162)
19. Brussino L, Badiu I, Sciascia S, et al. Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis. Clin Exp Allergy 2010; 40: 1642-7.
20. Lehtimäki L, Kankaanranta H, Saarelainen S, et al. Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD. Eur Respir J 2010; 35: 72-8.
21. Baraldi E, Carraro S, Alinovi R, et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003; 58: 505-9. (Pubitemid 36714012)
22. Gratziou C, Rovina N, Makris M, Simoes DC, Papapetropoulos A, Roussos C. Breath markers of oxidative stress and airway inflammation in Seasonal Allergic Rhinitis. Int J Immunopathol Pharmacol 2008; 21: 949-57.
23. Kiełbasa B, Moeller A, Sanak M, et al. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma. Pediatr Allergy Immunol 2008; 19: 660-9.